Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
<p dir="ltr">Phosphodiesterase 5 (PDE5) is one of the most well-studied phosphodiesterases (PDEs) that specifically targets cGMP typically generated by nitric oxide (NO)-mediated activation of the soluble guanylyl cyclase. Given the crucial role of cGMP generated through the activati...
محفوظ في:
| المؤلف الرئيسي: | Wesam S. Ahmed (10170053) (author) |
|---|---|
| مؤلفون آخرون: | Anupriya M. Geethakumari (17052375) (author), Kabir H. Biswas (5705864) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Coevolving residues distant from the ligand binding site are involved in GAF domain function
حسب: Wesam S. Ahmed (10170053)
منشور في: (2025) -
Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis
حسب: Eeshal Fatima (18255772)
منشور في: (2024) -
Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis
حسب: Ambanna Yappalparvi (21260018)
منشور في: (2024) -
Impact of synergistic interfacial modification on the electrochemical performance of LiNi0.5Mn1.5O4 cathode materials
حسب: Qureshi, Z.A.
منشور في: (2024) -
Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke
حسب: Fatima Alzahra Al Hamed (17115562)
منشور في: (2020)